the effect of bromocriptine at doses up to 20 mg/day was studied in a single-blind format with a placebo phase in 15 parkinson 's disease patients with mild-to-moderate disability who had not been previously treated with levodopa .
C0006230
bromocriptine
C0030567
parkinson 's disease